Inventor
WU ZHICAI
US38 patents
⚠️ This page may combine multiple inventors who share the name “WU ZHICAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
22 patentsUS8952166B2Feb 10, 2015
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME17 citations92
US10183981B2Jan 22, 2019
Insulin receptor partial agonists
MERCK SHARP & DOHME5 citations83
US9290517B2Mar 22, 2016
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
MERCK SHARP & DOHME8 citations82
US7750151B2Jul 6, 2010
Inhibitors of Akt activity
MERCK SHARP & DOHME10 citations82
US10017556B2Jul 10, 2018
Insulin receptor partial agonists
MERCK SHARP & DOHME3 citations72
US9868733B2Jan 16, 2018
Azabenzimidazole tetrahydrofuran derivatives
MERCK SHARP & DOHME4 citations72
US9540364B2Jan 10, 2017
Benzimidazole tetrahydrofuran derivatives
MERCK SHARP & DOHME6 citations72
US9527839B2Dec 27, 2016
Benzimidazole tetrahydropyran derivatives
MERCK SHARP & DOHME6 citations72
US9469608B2Oct 18, 2016
Thrombin inhibitors
MERCK SHARP & DOHME6 citations72
US9382243B2Jul 5, 2016
Azabenzimidazole tetrahydropyran derivatives
MERCK SHARP & DOHME4 citations72
US9751881B2Sep 5, 2017
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME2 citations71
US9556193B2Jan 31, 2017
Benzimidazole hexahydrofuro[3,2-b]furan derivatives
MERCK SHARP & DOHME4 citations71
US9206198B2Dec 8, 2015
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME2 citations62
US10689430B2Jun 23, 2020
Insulin receptor partial agonists
MERCK SHARP & DOHME1 citations61
US10508108B2Dec 17, 2019
Tricyclic compounds as inhibitors of mutant IDH enzymes
MERCK SHARP & DOHME1 citations59
US10800827B2Oct 13, 2020
Insulin receptor partial agonists
MERCK SHARP & DOHME0 citations51
US9403807B2Aug 2, 2016
Mineralocorticoid receptor antagonists
MERCK SHARP & DOHME0 citations50
US7879839B2Feb 1, 2011
Potassium channel inhibitors
MERCK SHARP & DOHME2 citations50
US9340530B2May 17, 2016
Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists
MERCK SHARP & DOHME2 citations49
US11014920B2May 25, 2021
Factor XIIa inhibitors
MERCK SHARP & DOHME0 citations47
US8030332B2Oct 4, 2011
Potassium channel inhibitors
MERCK SHARP & DOHME0 citations38
US10875851B2Dec 29, 2020
Factor XIIa inhibitors
MERCK SHARP & DOHME0 citations34
MERCK & CO INC
7 patentsUS7223738B2May 29, 2007
Inhibitors of Akt activity
MERCK & CO INC38 citations92
US7125888B2Oct 24, 2006
Tyrosine kinase inhibitors
MERCK & CO INC12 citations84
US7544677B2Jun 9, 2009
Inhibitors of Akt activity
MERCK & CO INC13 citations83
US7414055B2Aug 19, 2008
Inhibitors of Akt activity
MERCK & CO INC9 citations83
US7638530B2Dec 29, 2009
Inhibitors of Akt activity
MERCK & CO INC7 citations74
US7579355B2Aug 25, 2009
Inhibitors of Akt activity
MERCK & CO INC7 citations62
US7569589B2Aug 4, 2009
Potassium channel inhibitors
MERCK & CO INC0 citations40
MERCK SHARP & DOHME LLC
3 patentsUS12528786B2Jan 20, 2026
Plasma kallikrein inhibitors
MERCK SHARP & DOHME LLC0 citations45
US12440496B2Oct 14, 2025
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes
MERCK SHARP & DOHME LLC0 citations45
US12459927B2Nov 4, 2025
Plasma kallikrein inhibitors
MERCK SHARP & DOHME LLC0 citations44